Cargando…

Single-cell data analysis of malignant epithelial cell heterogeneity in lung adenocarcinoma for patient classification and prognosis prediction

Lung cancer is one of the leading causes of cancer-related death. Most advanced lung adenocarcinoma (LUAD) patients have poor survival because of drug resistance and relapse. Neglecting intratumoral heterogeneity might be one of the reasons for treatment insensitivity, while single-cell RNA sequenci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ran, Xu, Tong, Lu, Chenghao, Wang, Qi, Li, Bo, Peng, Jiaying, Zhao, Jun, Wang, Linyou, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559937/ https://www.ncbi.nlm.nih.gov/pubmed/37809682 http://dx.doi.org/10.1016/j.heliyon.2023.e20164

Ejemplares similares

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma
por: Chang, Xiaoyan, et al.
Publicado: (2022)

Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy
por: Wang, Chenghao, et al.
Publicado: (2022)

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
por: Wang, Chenghao, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development
por: Zhao, Jiaying, et al.
Publicado: (2022)

Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma
por: Huang, Zhihong, et al.
Publicado: (2022)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma
por: Xu, Yong, et al.
Publicado: (2022)

A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma
por: Wang, Youyu, et al.
Publicado: (2021)

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer
por: Peng, Bo, et al.
Publicado: (2023)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

T Cell-Mediated Tumor Killing-Related Classification of the Immune Microenvironment and Prognosis Prediction of Lung Adenocarcinoma
por: Ding, Peng, et al.
Publicado: (2022)

Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
por: Hua, Xing, et al.
Publicado: (2020)

Classification of lung adenocarcinoma based on stemness scores in bulk and single cell transcriptomes
por: Liu, Qian, et al.
Publicado: (2022)

Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma
por: Ge, Jie, et al.
Publicado: (2023)

Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma
por: Liu, Yafei, et al.
Publicado: (2020)

Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors
por: Liu, Qi-Fang, et al.
Publicado: (2021)

PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma
por: Liang, Xing, et al.
Publicado: (2023)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy
por: Qi, Wenqian, et al.
Publicado: (2023)

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
por: Wang, Chengdi, et al.
Publicado: (2022)

The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery
por: Wang, Jun, et al.
Publicado: (2022)

Comparative analysis of single-cell transcriptome reveals heterogeneity in the tumor microenvironment of lung adenocarcinoma and brain metastases
por: Liang, Jialu, et al.
Publicado: (2023)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

The relationship between tumor infiltrating immune cells and the prognosis of patients with lung adenocarcinoma
por: Tong, Zhuang, et al.
Publicado: (2023)

Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis
por: Li, Huawei, et al.
Publicado: (2022)

Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma
por: Zhang, Shengqiang, et al.
Publicado: (2021)

Heterogeneity and Differentiation Trajectories of Infiltrating CD8+ T Cells in Lung Adenocarcinoma
por: Song, Xiaojie, et al.
Publicado: (2022)

The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells
por: Xu, Ran, et al.
Publicado: (2021)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes
por: Liu, Qi, et al.
Publicado: (2022)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5k1iueev6gk1m14p2jah7u9ad1